Home > Balance Sheet > BIOCON

BIOCON
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Deferred Tax Assets / Liabilities ₹-314 Cr₹100 Cr₹74 Cr₹81 Cr₹-241 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of BIOCON ?

The latest Deferred Tax Assets / Liabilities ratio of BIOCON is ₹-314 Cr based on Mar2026 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2026₹-314 Cr
Mar2025₹100 Cr
Mar2024₹74 Cr
Mar2023₹81 Cr
Mar2022₹-241 Cr

How is Deferred Tax Assets / Liabilities of BIOCON Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2026 ₹-314 Cr
Negative
Mar2025 ₹100 Cr
34.77
Mar2024 ₹74 Cr
-8.17
Mar2023 ₹81 Cr
Positive
Mar2022 ₹-241 Cr -

Compare Deferred Tax Assets / Liabilities of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹57,210.6 Cr -2.6% -10% -0.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹424,466.0 Cr -0.8% -5.1% 6.3% Stock Analytics
DIVIS LABORATORIES ₹246,222.0 Cr -3.2% -1.4% 53.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,300.0 Cr -1.6% -6% 32.1% Stock Analytics
CIPLA ₹107,447.0 Cr 0% -3.6% -13.2% Stock Analytics
DR REDDYS LABORATORIES ₹103,471.0 Cr 3.1% 8.7% -1.5% Stock Analytics


BIOCON Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-2.6%

-10%

-0.8%

SENSEX

-0.1%

-2.3%

-10.7%


You may also like the below Video Courses